CENTOGENE NV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CENTOGENE NV and buy or sell other stocks, ETFs, and their options commission-free!About CNTGF
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate.
CEODavid Jiménez
CEODavid Jiménez
Employees493
Employees493
HeadquartersRostock, Mecklenburg-Vorpommern
HeadquartersRostock, Mecklenburg-Vorpommern
Founded2018
Founded2018
Employees493
Employees493
CNTGF Key Statistics
Market cap3.34M
Market cap3.34M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.69K
Average volume1.69K
High today$0.1151
High today$0.1151
Low today$0.1151
Low today$0.1151
Open price$0.1151
Open price$0.1151
Volume2.22K
Volume2.22K
52 Week high$0.705
52 Week high$0.705
52 Week low$0.0003
52 Week low$0.0003
Stock Snapshot
As of today, CENTOGENE NV(CNTGF) shares are valued at $0.12. The company's market cap stands at 3.34M.
As of 2026-01-09, CENTOGENE NV(CNTGF) stock has fluctuated between $0.12 and $0.12. The current price stands at $0.12, placing the stock 0.0% above today's low and 0.0% off the high.
The CENTOGENE NV(CNTGF)'s current trading volume is 2.22K, compared to an average daily volume of 1.69K.
During the past year, CENTOGENE NV(CNTGF) stock moved between $0.00 at its lowest and $0.71 at its peak.
During the past year, CENTOGENE NV(CNTGF) stock moved between $0.00 at its lowest and $0.71 at its peak.
People also own
Based on the portfolios of people who own CNTGF. This list is generated using Robinhood data, and it’s not a recommendation.